Antifibrinolytic effect

Tranexamic acid (Cyklokapron, Transamin) is a synthetic derivative of the amino acid lysine. It exerts its antifibrinolytic effect through the reversible blockade of lysine binding sites on plasminogen molecules. 

Tranexamic acid produces an antifibrinolytic effect by blocking the lysine binding site on plasminogen which is essential for binding to fibrin and thereby prevents the activation of plasminogen on the surface of fibrin. 

A third underlying mechanism seems to involve a reduction in concentrations of free protein S, again more pronounced with third-generation products. When protein S falls, the antifibrinolytic effect of the so-called thrombin-activated fibrinolysis inhibitor is increased in other words, fibrinolysis is impeded, with an increased risk of clotting problems (104). Again, however, these are recent methods, which were not available when the third-generation products were launched. 

Frederiksen MC, Bowsher DJ, Ruo TI, Henthorn TK, Ts ao C-H, Green D, Atkinson AJ Jr. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects. Clin Pharmacol Ther 1984 35 387-93. 

The antifibrinolytic effect of aminocaproic acid (s-aminocaproic acid,... 

The antifibrinolytic effect of aminocaproic add (e-aminocaproic acid, 6-aminohexanoic acid, EAGA) was discovered by Japanese workers , and the acid was subsequently shown to act mainly as a competitive inhibitor of plasminogen activation . The pharmacology of EAGA and similar compounds has been reviewed by McNicol and Douglas . 

Mecfianism of Action A systemic hemostatic that acts as an antifibrinolytic and an-tihemorrhagicby inhibitingthe activation of plasminogen activator substances. Therapeutic Effect Prevents formation of fibrin dots. 

Some adverse effects are associated with all antifibrinolytic agents, reflecting their effect on clot stability. Dissolution of extravascular blood clots may be resistant to physiological fibrinolysis. These drugs should not to be used to treat hematuria due to blood loss from the upper urinary tract, as this can provoke painful clot retention and even renal insufficiency associated with bilateral ureteric obstruction (25-31). 

Petruson B. A double-bhnd study to evaluate the effect in epistaxis with oral administration of the antifibrinolytic drug tranexamic acid (Cyklokapron). Acta Otolaryngol 1974 317(Suppl) 57-61. 

There are several potential causes for segmental necrosis of muscle fiber. The cause of this type of necrosis is not well understood but could be due to effects on the plasma membrane or the outer boundary of the muscle fiber. Aminocaproic acid (an antifibrinolytic medication used in the treatment of a subarachnoid hemorrhage), clofibrate (used to treat hyperlipedemia), emetine (found in ipecac syrup), cardiac glycosides, heroin, and phencyclidine have been associated with necrotizing myopathies. 

A recent stndy on the first dose-response comparison of a green tea and a black tea on normal hamsters after long-term supplementation and on a hamster model of atherosclerosis was reported. Both teas were equally effective in inhibiting atherosclerosis with the lower dose (0.0625% tea solution), decreasing it 26-40%, and the high dose (1.25% tea solntion), decreasing it 46-63%. Atherosclerosis was inhibited by three mechanisms hypolipidemic, antioxidant, and antifibrinolytic. There was a significant correlation between atherosclerosis and the three mechanisms. ... 

The compositions of fibrin sealants differ all consist of fibrinogen in combination with thrombin and in some cases they include factor XIII and/or an antifibrinolytic agent, which stabilizes the clot. Their adverse effects have been highlighted [ll ]. Bovine thrombin is potentially immunogenic and can cause immunological sequelae, anaphylaxis, and... 

---